CAHT Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
CAHT General Information
Description
Developer and manufacturer of biosimilar products based in Changchun, China. The venture develops biosimilar candidates for autoimmunity, ophthalmology and oncology diseases plus immune and inflammatory conditions.
Contact Information
Corporate Office
- Changchun Beihu Science Park
- Changchun, Jilin
- China
Corporate Office
- Changchun Beihu Science Park
- Changchun, Jilin
- China
CAHT Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CAHT Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CAHT Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CAHT FAQs
-
When was CAHT founded?
CAHT was founded in 2019.
-
Where is CAHT headquartered?
CAHT is headquartered in Changchun, China.
-
What industry is CAHT in?
CAHT’s primary industry is Drug Discovery.
-
Is CAHT a private or public company?
CAHT is a Private company.
-
What is the current valuation of CAHT?
The current valuation of CAHT is .
-
What is CAHT’s current revenue?
The current revenue for CAHT is .
-
Who are CAHT’s investors?
Alvotech and Changchun High and New Technology Industries Group have invested in CAHT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
